Cabazitaxel for Injection 45 mg (Cabazitaxel SOLUTION) 45 MG

Cabazitaxel for Injection 45 mg is a cancer treatment solution administered intravenously. This medication is used to manage certain types of cancer, offering a targeted approach to therapy. Learn more about its uses and effects.

Strength

45 MG

Manufacturer / TM Owner

SANDOZ CANADA INCORPORATED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cabazitaxel for Injection 45 mg is primarily used in the treatment of advanced or metastatic prostate cancer. This medication is often considered when other treatments have proven ineffective. It works by interfering with the division of cancer cells, helping to slow the progression of the disease. Patients and healthcare providers may explore cabazitaxel for injection uses to understand its role in cancer therapy.

Side Effects

Common effects of Cabazitaxel for Injection 45 mg may include fatigue, nausea, and a lowered white blood cell count. Some patients may experience diarrhea or vomiting. These effects can vary in intensity and duration, and it's important to discuss any concerns with a healthcare professional.

Precautions & Warnings

Cabazitaxel for Injection 45 mg should be handled with care, as it is a potent medication. It is essential to follow proper administration protocols to minimize the risk of side effects. Patients should be monitored regularly for any adverse reactions, and precautions should be taken to avoid exposure to the medication by others.

Avoid Interactions

Cabazitaxel for Injection 45 mg may interact with other medications, including those that affect the liver or immune system. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain supplements may also interact with cabazitaxel, so patients should consult their healthcare provider before making any changes to their regimen.

References

Frequently Asked Questions

Cabazitaxel for Injection 45 mg is used in the treatment of advanced or metastatic prostate cancer, particularly when other treatments have been ineffective.

Cabazitaxel for Injection 45 mg is administered intravenously by a healthcare professional in a clinical setting.

Common side effects may include fatigue, nausea, diarrhea, and a lowered white blood cell count.

Patients should consult their healthcare provider before combining cabazitaxel with other medications to avoid potential interactions.

Proper administration protocols should be followed, and patients should be monitored regularly for any adverse reactions.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.